Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Outset Medical, Inc.OM · Entity 7026 | Chief Financial Officer | May 15, 2025 | May 16, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Outset Medical, Inc.
Report date May 15, 2025 · Filed May 16, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,096 |
Reported balance
After 2025-05-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-05-15 · Sale · Disposed 584 · Balance 16,096 F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 1,104 shares of Common Stock underlying RSUs granted to the reporting person on August 5, 2021, January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2: These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the "Reverse Stock Split"). |
Filing footnotes · ownership attribution and instrument terms
F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 1,104 shares of Common Stock underlying RSUs granted to the reporting person on August 5, 2021, January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2: These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the "Reverse Stock Split").
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2022 Filed Apr 4, 2022 21:16 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 100 | $9.48 | $948.00 |
DisclosureSEC source: 0001484612-22-000031 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,589 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2022 Filed Mar 25, 2022 20:21 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 424 | $42.65 | $18,083.60 |
DisclosureSEC source: 0001484612-22-000028 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,489 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 22, 2022. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:27 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 477 | $41.72 | $19,900.44 |
DisclosureSEC source: 0001484612-22-000022 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,913 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 955 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 424 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2021 to February 28, 2022. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:56 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 1,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000013 · edgardoc.xml · nonDerivative · entry 2 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,966 F3 · shares: Represents portion of stock units granted to the reporting person on January 26, 2022 that will vest on December 31, 2024, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:56 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 27,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000013 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,428 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 26, 2022. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 26, 2023, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. F2 · balance_after: Includes 489 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2021 to August 31, 2021. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 20:21 UTC | Outset Medical, Inc. OM · Entity 7026 | PurchaseCommon Stock | 400 | $37.11 | $14,844.00 |
DisclosureSEC source: 0001484612-21-000051 · edgardoc.xml · nonDerivative · entry 2 Ahmed Nabeel · CIK 0001870610 · VP Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,589 Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 20:21 UTC | Outset Medical, Inc. OM · Entity 7026 | PurchaseCommon Stock | 600 | $37.15 | $22,290.00 |
DisclosureSEC source: 0001484612-21-000051 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · VP Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,189 Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 21:15 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 18,070 | $0.00 Strike: $39.03 | $0.00 |
DisclosureSEC source: 0001484612-21-000050 · edgardoc.xml · derivative · entry 2 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,070 Underlying: Common Stock · 18,070 shares Expires 2031-08-05 F2 · derivative.exercise_date: This option vests 25% on August 5, 2022 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting period. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 21:15 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 8,398 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-21-000050 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,589 F1 · shares: Represent Restricted Stock Units (RSUs) granted to the reporting person on August 5, 2021. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 25% on August 5, 2022, then quarterly over three years on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| July 16, 2021 Filed Jul 19, 2021 20:11 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 1,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-21-000044 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 F1 · shares: Represent Restricted Stock Units (RSUs) granted to the reporting person on July 16, 2021. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest in full on July 16, 2022, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.